Cabaletta Bio Valuation
| CABA Stock | USD 2.57 0.18 6.55% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Cabaletta Bio shows a prevailing Real Value of $5.11 per share. The current price of the firm is $2.57. Our model approximates the value of Cabaletta Bio from analyzing the firm fundamentals such as return on equity of -1.01, and Current Valuation of 140.69 M as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Cabaletta Bio's price fluctuation is unstable at this time. Calculation of the real value of Cabaletta Bio is based on 3 months time horizon. Increasing Cabaletta Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Cabaletta Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cabaletta Stock. However, Cabaletta Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.57 | Real 5.11 | Target 13.13 | Hype 2.57 | Naive 2.75 |
The real value of Cabaletta Stock, also known as its intrinsic value, is the underlying worth of Cabaletta Bio Company, which is reflected in its stock price. It is based on Cabaletta Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Cabaletta Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Cabaletta Bio helps investors to forecast how Cabaletta stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cabaletta Bio more accurately as focusing exclusively on Cabaletta Bio's fundamentals will not take into account other important factors: Cabaletta Bio Cash |
|
Cabaletta Bio Total Value Analysis
Cabaletta Bio is currently forecasted to have valuation of 140.69 M with market capitalization of 264.73 M, debt of 15.6 M, and cash on hands of 96.81 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Cabaletta Bio fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
140.69 M | 264.73 M | 15.6 M | 96.81 M |
Cabaletta Bio Asset Utilization
One of the ways to look at asset utilization of Cabaletta is to check how much profit was generated for every dollar of assets it reports. Cabaletta Bio shows a negative utilization of assets of -0.52 percent, losing $0.005182 for each dollar of assets held by the firm. Unsuccessful asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Cabaletta Bio shows how unproductive it operates for each dollar spent on its assets.Cabaletta Bio Profitability Analysis
Considering Cabaletta Bio's profitability and operating efficiency indicators, Cabaletta Bio may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Cabaletta Bio's ability to earn profits and add value for shareholders.Net Loss | First Reported 2018-03-31 | Previous Quarter -45.1 M | Current Value -44.9 M | Quarterly Volatility 12.2 M |
For Cabaletta Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cabaletta Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cabaletta Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cabaletta Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cabaletta Bio over time as well as its relative position and ranking within its peers.
Cabaletta Bio Earnings per Share Projection vs Actual
The next projected EPS of Cabaletta Bio is estimated to be -0.4193 with future projections ranging from a low of -0.4775 to a high of -0.2925. Cabaletta Bio's most recent 12-month trailing earnings per share (EPS TTM) is at -2.4. Please be aware that the consensus of earnings estimates for Cabaletta Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Cabaletta Bio Earnings Estimation Breakdown
The calculation of Cabaletta Bio's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cabaletta Bio is estimated to be -0.4193 with the future projection ranging from a low of -0.4775 to a high of -0.2925. Please be aware that this consensus of annual earnings estimates for Cabaletta Bio is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.48 Lowest | Expected EPS | -0.29 Highest |
Cabaletta Bio Earnings Projection Consensus
Suppose the current estimates of Cabaletta Bio's value are higher than the current market price of the Cabaletta Bio stock. In this case, investors may conclude that Cabaletta Bio is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cabaletta Bio's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 10 | 81.88% | 0.0 | -0.4193 | -2.4 |
Cabaletta Bio Ownership Allocation
Cabaletta Bio holds a total of 96.27 Million outstanding shares. The majority of Cabaletta Bio outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cabaletta Bio to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cabaletta Bio. Please pay attention to any change in the institutional holdings of Cabaletta Bio as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Cabaletta Bio Profitability Analysis
Net Loss for the year was (115.86 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cabaletta Bio's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cabaletta Bio and how it compares across the competition.
About Cabaletta Bio Valuation
The stock valuation mechanism determines Cabaletta Bio's current worth on a weekly basis. Our valuation model uses a comparative analysis of Cabaletta Bio. We calculate exposure to Cabaletta Bio's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Cabaletta Bio's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -4.3 M | -4.1 M |
Cabaletta Bio Current Valuation Indicators
Valuation refers to the process of determining the present value of Cabaletta Bio and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Cabaletta we look at many different elements of the entity such as Cabaletta's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Cabaletta Bio, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Cabaletta Bio's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Cabaletta Bio's worth.Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |